Long-term survival of locally advanced stage III non-small cell lung cancer patients treated with chemoradiotherapy and perspectives for the treatment with immunotherapy

Categoria dell'articolo: Research Article

Pubblicato online: 21 feb 2018

Pagine: 281 - 288

Ricevuto: 22 nov 2017

Accettato: 30 nov 2017

DOI: https://doi.org/10.2478/raon-2018-0009

Parole chiave

locally advanced NSCLC, survival, immunotherapy, PD-L1 expression, chemoradiotherapy

© 2018 Martina Vrankar, Karmen Stanic, published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.